Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation.

Autor: Sheikh IN; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Uwaezuoke D; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Okeleji O; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Quesada A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Herzog CE; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ragoonanan D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tewari P; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Petropoulos D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nunez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Khazal S; Department of Pediatric Hematology/Oncology, Loma Linda University, Loma Linda, California, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec 19, pp. e31489. Date of Electronic Publication: 2024 Dec 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.

Autor: Cuglievan B; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Bcuglievan@mdanderson.org., Connors J; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., He J; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khazal S; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yedururi S; Division of Radiology, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai J; Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garces S; Division of Pathology, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Quesada AE; Division of Pathology, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth M; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia M; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCall D; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gibson A; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ragoonanan D; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petropoulos D; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tewari P; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nunez C; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahadeo KM; Division of Pediatric Transplantation and Cellular Therapy, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lamble AJ; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Pawlowska A; Division of Pediatric Hematology/Oncology, and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA, USA., Hammond D; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Senapati J; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gangat N; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Konopleva M; Department of Oncology, Montefiore Einstein Cancer Center, Bronx, NY, USA., Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Pemmaraju N; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1767-1778. Date of Electronic Publication: 2023 Jul 14.

Effects of NaCl and CaCl 2 as Eustress Factors on Growth, Yield, and Mineral Composition of Hydroponically Grown Valerianella locusta .

Autor: Voutsinos-Frantzis O; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Karavidas I; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Petropoulos D; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Zioviris G; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Fortis D; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Ntanasi T; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Ropokis A; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Karkanis A; Department of Agriculture Crop Production and Rural Environment, University of Thessaly, 38446 Volos, Greece., Sabatino L; Department of Agricultural, Food and Forest Sciences (SAAF), University of Palermo, Viale delle Scienze, Ed. 5, 90128 Palermo, Italy., Savvas D; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece., Ntatsi G; Laboratory of Vegetable Production, Department of Crop Science, Agricultural University of Athens, 11855 Athens, Greece.

Publikováno v: Plants (Basel, Switzerland) [Plants (Basel)] 2023 Mar 26; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 26.

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.

Autor: Singh H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McCarty J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Dai C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gaballa MR; Cellular Therapy Program and Bone Marrow Transplant Unit, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States., Ammari M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olivares S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huls H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., De Groot E; Alaunos Therapeutics, Boston, MA, United States., Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Petropoulos D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olson AL; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Im JS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Khouri I; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hosing CM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cooper LJN; Alaunos Therapeutics, Boston, MA, United States., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Nov 10; Vol. 13, pp. 1032397. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).